The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Sanofi
Evaluating the role of immune-checkpoint inhibitor (ICI) combinations in patients (pts) with unselected “cold” tumors enrolled in early clinical trials (CT).
 
Omar Saavedra Santa Gadea
Travel, Accommodations, Expenses - Kyowa Kirin; MSD Oncology
 
Alberto Hernando-Calvo
Travel, Accommodations, Expenses - Kyowa Kirin International; Merck Serono
 
Roger Berche
No Relationships to Disclose
 
Maria Vieito
Consulting or Advisory Role - Debiopharm Group; Roche; TFS
Travel, Accommodations, Expenses - Roche
 
Irene Brana
Consulting or Advisory Role - Achilles Therapeutics; Cancer Expert Now; eTheRNA Immunotherapies; Merck Sharp & Dohme; Rakuten Medical; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gliknik; Janssen Oncology; Kura Oncology; Merck Sharp & Dohme; Nanobiotix; Novartis; Orion; Pfizer; Roche; Seagen (Inst); Shattuck Labs
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck Serono
 
Ignacio Matos
Speakers' Bureau - MSD
Research Funding - ESMO
 
Guzman Alonso
No Relationships to Disclose
 
Vladimir Galvao
No Relationships to Disclose
 
Analia Azaro
Consulting or Advisory Role - Amcure
Research Funding - AMCURE (Inst)
 
Honey Kumar Oberoi
No Relationships to Disclose
 
Natassia Ann Wornham
No Relationships to Disclose
 
Javier Ros
No Relationships to Disclose
 
Juan Francisco Grau Béjar
No Relationships to Disclose
 
Carmen García
No Relationships to Disclose
 
Teresa Macarulla
Consulting or Advisory Role - AstraZeneca; Baxalta; Baxter; Celgene; Eisai; Genzyme; Incyte; Ipsen; Lilly; Menarini; MSD; Polaris; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Shire; Surface Oncology
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Elena Elez
Honoraria - Abbvie/Genentech (Inst); Amgen (Inst); Array BioPharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; GlaxoSmithKline (Inst); Merck Serono; MSD (Inst); Novartis (Inst); Roche; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
Research Funding - Amgen; Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck Serono; Roche (Inst); Sanofi/Aventis (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Avvinity; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Seagen; Servier; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc
Other Relationship - Imedex; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
Rodrigo Dienstmann
Employment - Oncoclínicas
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Speakers' Bureau - Amgen; Ipsen; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Merck
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme